EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Anti-Aggregative Potential of Resolvin E1 on Human Platelets

Patrycja Szymańska iD, Bogusława Luzak iD, Katarzyna Miłowska iD, Jacek Golański

Molecules · 2023

DOI: 10.3390/molecules28145323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Patrycja Szymańska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haemostasis and Haemostatic Disorders, Chair of Biomedical Sciences, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland. Hauptthemen laut MEDLINE: Blood Platelets, Fatty Acids, Omega-3. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resolvin E1 is a metabolite of eicosapentaenoic acid (EPA) which is one of the omega-3 polyunsaturated fatty acids (omega-3 PUFAs). The antiplatelet properties of omega-3 PUFAs are well known, but the effect of resolvin E1 on platelets via the collagen receptors is extremely poorly reported. We investigated the effect of resolvin E1 on collagen-induced platelet aggregation, activation, and reactivity, and also platelet membrane fluidity. The ultimate and statistically significant results showed that resolvin E1 may inhibit platelet reactivity due to the reduction of collagen-induced platelet aggregation in platelet-rich plasma and isolated platelets, but not in whole blood. Also, resolvin E1 significantly reduced P-selectin exposure on collagen-stimulated platelets. Moreover, we demonstrated that resolvin E1 can maintain platelet membrane structure (without increasing membrane fluidity). The association between platelet reactivity and membrane fluidity, including resolvin E1 and collagen receptors requires further research. However, the goal of this study was to shed light on the molecular mechanisms behind the anti-aggregative effects of resolvin E1 on platelets, which are still not fully clarified. We also indicate an innovative research direction focused on further analysis and then use of omega-3 PUFAs metabolites as antiplatelet compounds for future applications in the treatment and prevention of cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsFatty Acids, Omega-3HumansEicosapentaenoic AcidPlatelet AggregationCollagen

Stichwörter der Autor:innen

EPAGPVIaggregationanti-aggregativecollagenomega-3 PUFAsplatelet membrane fluidityplateletsreactivityresolvin E1

Substanzen

5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acidEicosapentaenoic AcidFatty Acids, Omega-3Collagen

Autor:innen und Institutionen

  • Department of Haemostasis and Haemostatic Disorders, Chair of Biomedical Sciences, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
  • Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.

ORCID-Profile: Patrycja Szymańska, Bogusława Luzak, Katarzyna Miłowska

Förderung

  • Medical University of Lodz

Zitieren

APA

Szymańska, P., Luzak, B., Miłowska, K., & Golański, J. (2023). The Anti-Aggregative Potential of Resolvin E1 on Human Platelets. Molecules. https://doi.org/10.3390/molecules28145323

Vancouver

Szymańska P, Luzak B, Miłowska K, Golański J. The Anti-Aggregative Potential of Resolvin E1 on Human Platelets. Molecules. 2023. doi:10.3390/molecules28145323

BibTeX
@article{Szymaska2023,
  author = {Szymańska, Patrycja and Luzak, Bogusława and Miłowska, Katarzyna and Golański, Jacek},
  title = {The Anti-Aggregative Potential of Resolvin E1 on Human Platelets},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28145323}
}
Kostenlos starten →